Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Dennis

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
RNA (New York, N.Y.)|July 1, 2005
Characterization of a highly variable eutherian microRNA geneHristo B Houbaviy, Lucas Dennis, Rudolf Jaenisch, et al.
Plos Computational Biology|July 18, 2014
Modeling bi-modality improves characterization of cell cycle on gene expression in single cellsAndrew McDavid, Lucas Dennis, Patrick Danaher, et al.
The Journal of Molecular Diagnostics : JMD|March 18, 2022
Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non-Small Cell Lung Cancer and EGFR- and KRAS-Mutated TumorsMeijuan Li, Lei Yang, Jason Hughes, et al.
Journal for Immunotherapy of Cancer|February 28, 2017
Gene expression markers of Tumor Infiltrating LeukocytesPatrick Danaher, Sarah Warren, Lucas Dennis, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
Molecular Oncology|March 26, 2022
Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinibRafal Dziadziuszko, Tiffany Hung, Kun Wang, et al.
Plos One|November 17, 2025
Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samplesWenshu Li, Jeffrey A Leibowitz, Shuoguo Wang, et al.
Plos One|September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor originRyan Woodhouse, Meijuan Li, Jason Hughes, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
Clinical Chemistry|October 9, 2021
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer PatientsRichard S P Huang, Jinpeng Xiao, Dean C Pavlick, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
RNA (New York, N.Y.)|July 1, 2005
Characterization of a highly variable eutherian microRNA geneHristo B Houbaviy, Lucas Dennis, Rudolf Jaenisch, et al.
Plos Computational Biology|July 18, 2014
Modeling bi-modality improves characterization of cell cycle on gene expression in single cellsAndrew McDavid, Lucas Dennis, Patrick Danaher, et al.
The Journal of Molecular Diagnostics : JMD|March 18, 2022
Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non-Small Cell Lung Cancer and EGFR- and KRAS-Mutated TumorsMeijuan Li, Lei Yang, Jason Hughes, et al.
Journal for Immunotherapy of Cancer|February 28, 2017
Gene expression markers of Tumor Infiltrating LeukocytesPatrick Danaher, Sarah Warren, Lucas Dennis, et al.
NPJ Precision Oncology|June 17, 2025
Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fractionSaumya D Sisoudiya, Hanna Tukachinsky, Rachel B Keller-Evans, et al.
Molecular Oncology|March 26, 2022
Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinibRafal Dziadziuszko, Tiffany Hung, Kun Wang, et al.
Plos One|November 17, 2025
Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samplesWenshu Li, Jeffrey A Leibowitz, Shuoguo Wang, et al.
Plos One|September 25, 2020
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor originRyan Woodhouse, Meijuan Li, Jason Hughes, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
Clinical Chemistry|October 9, 2021
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer PatientsRichard S P Huang, Jinpeng Xiao, Dean C Pavlick, et al.
Pageof 2